MK1903

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK1903, covering 2010-09-22 to 2010-09-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate MK1903 in Patients With Dyslipidemia (MK1903-004) [Phase 2]